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Background
Subarachnoid hemorrhage (SAH) is a subtype of stroke with significant morbidity and mortality; SAH patients experience neurological deficits [1] , which are a result of early brain injury (EBI) and cerebral vasospasm (CVS) [2] . EBI is the acute brain injury occurring within the first 72 h after SAH (e.g., BBB disruption) [1] .
Several factors and pathways, such as inflammation and apoptosis, are involved in BBB injury after SAH [3] . Previous studies have demonstrated the involvement of TLR4/NF-κB signaling pathway in the development of EBI after SAH [4] . TLR4 is expressed in various cell types within the central nervous system and may be an A C C E P T E D M A N U S C R I P T important therapeutic target in the treatment of neuroinflammation [5] . Salvia miltiorrhiza (SM) is widely used for treating disturbed microcirculation and cerebral vessel diseases [6, 7] . Dihydroxyphenyl lactic acid (DLA) is the active ingredient in SM. It is water-soluble and has several proven properties including anti-inflammatory, anti-oxidant, and anti-apoptotic actions [8] . However, the effects of DLA on microvascular injury in the brain after SAH still needs further investigation. In this study, we have explored the role of DLA in maintaining BBB integrity following SAH and investigated its potential mechanism.
Methods
All the methods used in this study were assessed and approved by the Animal 
Establishment of SAH model
Male Sprague-Dawley rats (weighing 300-350 g) were housed in a 12-hour light/dark cycle cage. The cage was temperature and humidity controlled and allowed free access to food and water. The animals were randomly divided into four groups:
sham (n = 40), SAH (n = 46), SAH + vehicle (n = 44), and SAH + DLA treatment groups (n = 40).
The SAH model was established using endovascular perforation method, as previously mentioned [9, 10] . The animals were first anesthetized. Anesthesia was A C C E P T E D M A N U S C R I P T induced using 4% isoflurane in a mixture of 60% medical air and 40% oxygen and then maintained using 2% isoflurane. Body temperature was maintained at 37 ± 0.5 ℃. A 4-0 monofilament nylon suture was introduced through the right internal carotid artery until it perforated the junction of the middle and anterior cerebral arteries. The sham animals underwent the same operation, except the suture was withdrawn when resistance was felt. One hour following SAH, either DLA (10 mg/kg) or normal saline (vehicle control) was injected into the femoral vein of the animal, according to its group.
Brain water content
The water content in the brain was evaluated as previously mentioned [11] . The animal was anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg; Abbott Laboratory, North Chicago, IL, USA) and the brain was removed at 24 h after SAH. The brain samples were then weighed twice, once immediately after removal (wet weight) and again following drying in an oven at 105 ℃ for 24 h (dry weight). The water content was calculated as follows: [(wet weight-dry weight)/wet weight]×100%.
Neurobehavioral deficit evaluation
The neurological deficits were evaluated at 24 h after SAH using the modified Garcia score system [9] . It is an 18-point sensory-motor assessment system consisting of six items, with scores of 0-3 or 1-3 for each item (max score = 18). The items include spontaneous activity, symmetry of the limb movement, forepaw outstretching, climbing, body proprioception, and whisker stimulation response.
Magnetic resonance imaging examination
Magnetic resonance imaging (MRI; T2 weighted image/T2WI) examination was performed as previously reported [12] . The hippocampus was decided upon as the region of interest (ROI), as it is highly sensitive to hypoxia or edema after SAH [13] .
At 24 h after SAH, the animal was anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg). It was then placed on a frame in the prone position and introduced into a 3.0 Tesla animal scanner (Siemens, Germany). The animal's head was fixed into a "birdcage coil" (diameter: ~30 mm). In order to reduce movement artefacts, a muscle relaxant was administrated continuously via the femoral artery (diluted atracurium besilate: initial bolus 4 mg/kg, followed by 4.5 mg/h; Glaxo Wellcome). 
BBB permeability
BBB permeability was assessed as previously reported [14] . Under anesthesia, the animals were injected intravenously with Evans blue dye (4%; 2.5 mL/kg). The dye was injected into the jugular vein and allowed to circulate for 1 h. The rats were perfused with 200 ml of 0.1 mol/L phosphate buffer saline (PBS) via the left ventricle. 
Immunohistochemistry staining
The animals were anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg). Their left ventricles were perfused using 200 ml of ice-cold 0.1 mol/L PBS and 400 ml of 4% paraformaldehyde (pH = 7.4). The brains were then post-fixed in the same fixative overnight. The brain samples were embedded in paraffin, and coronal sections measuring 10 μm in thickness were cut using a cryostat (Leica Microsystems, Bannockburn, IL).
The sections were incubated overnight at 4 ℃ with the primary antibodies for TLR4 and p-p38 MAPK (1:200, Santa Cruz Inc., CA). The sections were then treated with corresponding fluorescent labeled secondary antibodies (1:400, Santa Cruz Inc., CA). The results were observed with an Olympus BX51 microscope. The control serum-which was used instead of the primary antibody-provided a negative control [15] .
IgG staining
To locate the BBB leakage morphologically, IgG immunohistochemistry staining was performed as previously mentioned [16] . The sections were incubated overnight
with goat anti-rat IgG biotin-conjugated antibody (1:100, Santa Cruz Inc., CA), at 4 °C and then treated with the corresponding Avidin-Biotin Complex staining kit.
Western blot
At 24 h after SAH, protein extraction was done by homogenizing the brain samples with RIPA lysis buffer (Santa Cruz Inc., CA, USA) using further centrifugation (14000 G, 4 °C, 30 min). The protein concentration in the supernatant was measured using a detergent compatible assay (Bio-Rad, DC protein assay). The protein samples (50μg) were loaded on an SDS-PAGE gel, electrophoresed, and then transferred onto a nitrocellulose membrane. The membrane was incubated overnight with the primary antibodies at 4 °C, and then incubated for 1 h with the corresponding secondary antibodies at room temperature. The immunoblots were then probed using an ECL Plus chemiluminescence reagent kit (Amersham Biosciences, Arlington Heights, IL). The results were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD, USA) [17] .
Data analysis
In this study, all data was expressed as the mean±s.e.m, and the multiple comparisons were analyzed using one-way analysis of variance (one-way ANOVA), followed by Tukey's multiple comparison post hoc analysis using SPSS 20.0 software. The neurological scores were compared with the Kruskal-Wallis one-way ANOVA on ranks, and then followed by Steel-Dwass test for multiple comparisons. A p value of <0.05 was considered as statistically significant.
Effect of DLA on mortality and neurological deficits
The mortality in the SAH group (38.2%, 19/46) and the SAH + vehicle group (35.2%, 18/44) was significantly higher when compared to the sham group (0/40) (p<0.05) (Fig. 1A) . After DLA treatment, the mortality of animals that had undergone SAH operation was markedly lower (27.5%, 11/40) (p<0.05) (Fig. 1A) .
The Evans blue content in the brains of the SAH group (2.83 ± 0.34 μg/g) and SAH + vehicle group (2.88 ± 0.31 μg/g) was significantly higher compared to that of the sham group (0.82 ± 0.11 μg/g, p<0.05). However, the Evans blue content of DLA treated group was markedly lower (1.39 ± 0.26 μg/g, p<0.05) (Fig. 1B) .
The neurological scores of the animals in SAH and SAH + vehicle groups were markedly lower following SAH compared with that of sham group (p<0.05); however, after DLA treatment, the neurological deficits were significantly reduced (p<0.05) (Fig. 1C) . The brain water content of the left and right hemispheres in the SAH group (80.5 ± 1.2% and 80.4 ± 1.3%) and the SAH + vehicle group (81.2 ± 1.5% and 80.0 ± 1.4%) was significantly higher than that of the sham group (77.8 ± 0.2% and 78.0 ± 0.3% respectively) (p<0.05). In DLA treatment group, the brain water content in both hemispheres were markedly lowered (left: 78.9 ± 0.8% and right: 78.8 ± 0.9%) (p<0.05). On the other hand, DLA has little effect on the water content of the brain stem and cerebellum (Fig. 1D) .
The MRI examination results indicated marked edema in the hippocampus
following SAH in the SAH and SAH + vehicle groups (Fig. 2A2 and 2A3 ). In addition, treatment with DLA significantly alleviated cerebral edema after SAH ( Fig.   2A4 and 2B) .
Compared with the sham group, the IgG staining positive product was diffusely distributed around the microvessels in the SAH and SAH + vehicle groups. In addition, the surrounding glial cells were also positively stained due to the engulfing of the IgG antibodies which penetrated into the parenchyma from the microvessels after SAH (Fig. 3A1-3 ). In the DLA treatment group, both the amount of IgG staining positive product around the microvessels and the number of activated glial cells were significantly lower (Fig. 3A4) .
Potential mechanism of DLA effects
Immunofluorescence staining was performed to explore the potential mechanism of DLA effects after SAH. After SAH, the levels of TLR4 and NF-κB were found to be simultaneously elevated and colocalized in the nucleus of the endothelial cells (Fig. 3B1-4) . These results indicated that the TLR4 and p-p65 pathways were activated and involved in the injury mechanism after SAH.
Western blot analysis of the hippocampus after SAH showed markedly elevated levels of TLR4, p-p38 MAPK, pro-inflammatory factors such as p-p65 and TNF-α, and pro-apoptotic factors such as p-p53 and cleaved-caspase-3. The elevation of these factors following SAH could be attenuated with DLA treatment (Fig. 4) .
We have analyzed the relationship of brain water content(r=0.87,p<0.05) and neurological function (r=0.85,p<0.05) with TLR-4/p-p38MAPK pathway.
A C C E P T E D
In this study, we explored the protective role of DLA in maintaining BBB integrity after SAH, through its anti-inflammatory and anti-apoptotic effects.
After SAH, there are some physiological derangements such as raised intracranial pressure, decreased cerebral blood flow, and global cerebral ischemia due to the ruptured aneurysm. These pathologies lead to early brain injury such as BBB disruption and neurocyte death (mediated by apoptosis, inflammation, and oxidative stress) [1, 18] . Previous evidence suggests that inflammatory cascades are involved in BBB injury after SAH [18, 19] .
The BBB is composed of endothelial cells, tight junctions, and basal membrane [20] . These are damaged by the inflammatory and apoptotic factors, which are elevated following SAH [1]. BBB disruption can lead to the leakage of water and macromolecules (e.g., leakage of IgG can be measured by staining with Evans blue) from plasma into brain parenchyma [21] . In this study, both the Evans blue content and brain water content were significantly increased after SAH. Furthermore, the IgG staining results indicated that IgG can penetrate from within the microvessels into the brain parenchyma. These results indicate an obvious BBB disruption following the SAH.
To clarify the potential mechanism of BBB disruption, we further examined the pro-inflammatory and pro-apoptotic pathway following SAH. The toll-like receptors [22, 23] . TLR4, a member of the TLR family, plays a pivotal role in host defense. Conversely, inappropriate TLR4 activation can lead to some inflammatory and autoimmune diseases [24] [25] [26] . Once activated, TLR4 can recruit MyD88 to initiate MAPKs and NF-κB signal pathways, which consequently lead to the activation of transcription factors such as AP-1 or NF-κB [27] . In this study, we found that TLR4 and NF-κB were simultaneously activated in the endothelial cells of the brain after SAH. Furthermore, the levels of TLR4 and its downstream NF-κB and pp38 MAPK were significantly increased, and the development of brain edema and neurological function deficits were markedly correlated with TLR-4/p-p38MAPK pathway. Levels of pro-apoptotic protein caspase-3 and pro-inflammatory protein TNF-ɑ were also significantly elevated. This indicated that there was evident apoptosis and inflammation induced, at least in part, by the activated TLR4 pathway in the microvessels after SAH. These results were in accordance with the previous reports [28] . In the future study, the antagonist for TLR4 should be applied in order to verify the role of TLR4 and p-p38 MAPK pathways in brain injury.
DLA is an important water-soluble component derived from SM. It has many properties including anti-inflammatory, anti-free radical, and anti-apoptotic effects [6, [29] [30] [31] [32] . However, its mechanism was still unclear. In the present study, we demonstrated that DLA treatment after SAH could attenuate brain edema, neurological deficits, and BBB disruption. To explore the protective mechanism of A C C E P T E D M A N U S C R I P T DLA after SAH, we performed immunohistochemistry staining and western blot. We found that the expression levels of TLR4 and its downstream NF-κB and p-p38 MAPK, pro-apoptotic protein caspase-3, and pro-inflammatory protein TNF-ɑ were markedly decreased. These results confirmed that the activation of TLR4-NF-κB cascade was involved in the brain injury following SAH. It can also attenuate advanced glycation end products(AGE) to mediate neuroinflammation in cognitive deficit mice [33] . We have analyzed the relationship of edema(r=0.87,p<0.05) and neurological function (r=0.85,p<0.05) with TLR-4/p-p38MAPK pathway. The results indicated that TLR-4/p-p38MAPK pathway played important roles in the development of BBB injury after SAH, which could be attenuated by DLA through suppressing this pathway. The anti-anxiety effect of DLA was reported at a concentration of 3 or 10 mg/kg (intravenous injection) [34] . Moreover, 30 mg/kg and 60 mg/kg of DLA were also applied to explore its neuroprotective effects [32] . In this study, we used 10 mg/kg dose of DLA (iv) based on a previous study.
In this study, we did not explore the anti-oxidative effects of DLA following SAH, although it is known to inhibit oxidative stress in human peritoneal mesothelial cells [35] . In the future study, the other protective mechanism, e.g. anti-oxidative effect following SAH should be studied.
Conclusions
Our results demonstrate that DLA can maintain BBB integrity following SAH, through its anti-inflammatory and anti-apoptotic effects via suppression of TLR4 and 
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